Mater Misericordiae University Hospital
Dublin, Ireland
Location status: Recruiting
Location contact
Jake McDonnell, MD
CONTACT
Joseph Butler, MD
PRINCIPAL_INVESTIGATOR
Stacy Darwish, MD
SUB_INVESTIGATOR
NCT Number: NCT06383949
This is a real world data collection observational study at a single site. There are both prospective and retrospective cohorts. The study will examine the safety and effectiveness of the Synergy cervical disc system in patients with degenerative cervical disc disease.
Interested in participating?
Request Info21 year and older
All sexes
Observational
Dublin, Ireland
Location status: Recruiting
Jake McDonnell, MD
CONTACT
Joseph Butler, MD
PRINCIPAL_INVESTIGATOR
Stacy Darwish, MD
SUB_INVESTIGATOR
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Age 21 or above at the time of the surgery. Have had (retrospective cohort) or the decision has been made to have (prospective cohort) the Synergy Disc implanted Skeletally mature patients for reconstruction of the disc from C3-C7 following a single or multiple level discectomy for intractable radiculopathy
Intractable radiculopathy and/or myelopathy with at least one of the following producing symptomatic nerve root and/or spinal cord compression:
herniated disc and/or osteophyte formation Symptomatic nerve root and/or spinal cord compression documented by patient history (arm or neck pain and/or neurologic deficit) and imaging (CT, MRI, x-rays, etc.) Failed a minimum of 6 weeks conservative treatment Written informed consent given by subject.
Exclusion criteria
Moderate to advanced spondylosis Diagnosis of osteoporosis Active systemic infection or infection at the operative site Pregnancy Marked cervical instability on lateral, coronal, or flexion/extension radiographs Cervical spine condition other than symptomatic cervical disc disease requiring surgical treatment at the involved level Severe pathology of the facet joints of the involved vertebral bodies Previous diagnosis of osteopenia or osteomalacia More than one immobile vertebral level between C1 and T1 from any cause Morbid obesity Vulnerable person (pregnant patients, emergency cases, children, prisoners and people without mental capacity)-
motion preservation disc
Time frame: 12 months
Neck disability Index improvement of >15 pts (out of 100) in subjects by 12 months post operative compared with baseline. A lower score is a better score.
Time frame: 12 months
Absence of major device related adverse events defined as radiographic failure, neurologic failure or failure by adverse event
Time frame: pre-operative, 6 week, 3 month, 6 month, 12 month, 24 month
Pain will evaluated by the Visual analog scale (VAS) (place a line from zero where there is no pain to 10 which is the worst pain imaginable), by NRS (circle a number from zero to ten where zero equals no pain and ten is worst imaginable) to or a verbal description that the doctor writes down, per the site's Standard of Care. A change of at least 20 mm will be considered clinically significant. Neck pain as measured on a 100mm VAS at baseline and at each follow-up timepoint. Left and Right arm/shoulder pain as measured on a 100 mm VAS at baseline and at each follow up time-point.
Time frame: 6 week, 3 month, 6 month, 12 month, 24 month
patient completed questionnaire on their satisfaction with the disc replacement surgery
Time frame: pre-operative, 6 week, 3 month, 6 month, 12 month, 24 month
maintenance or improvement in neurologic status compared with baseline will be assessed using a defined numeric scale ranging from 0 (normal) to 5 (deficit)
Time frame: pre-operative, 6 week, 3 month, 6 month, 12 month, 24 month
Disease status as characterized by physician at each time point
Time frame: 6 week, 3 month, 6 month, 12 month, 24 month
surgical outcome characterized by physician at each post operative visit
Contact information is provided by the study sponsor or research team.
Robyn Capobianco, PhD
CONTACT
Stacy Gardner
CONTACT
Synergy Spine Solutions
Industry
A Single Site Post-Market Data Collection Protocol to Evaluate the Performance of Synergy Spine Solutions Synergy Disc®
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00637156
Central Nervous System Diseases, Cervical Degenerative Disc Disease
Huntsville, Alabama, United States
View Trial DetailsNCT00437190
Central Nervous System Diseases, Cervical Degenerative Disc Disease
Phoenix, Arizona, United States
View Trial DetailsNCT04122248
Cervical Degenerative Disc Disease, Cervical Disc Herniation
Phoenix, Arizona, United States
View Trial DetailsNCT06383962
Cervical Degenerative Disc Disease
Birmingham, United Kingdom
View Trial Details